Cancer vaccines' efficacy can be tested on an organ-on-a-chip platform that replicates age-related immune decline.

We generally consider cancer a disease of aging, as the rates of almost all types of cancer increase with age.

Cellular, animal and computational models of the disease are providing fresh insights into biology and treatment.

Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates ...

Los Angeles, CA – September 3, 2025 - Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates ...

What if testing cancer treatments no longer required extensive animal trials? Organ-on-chip technology is revolutionizing medical research by offering a more precise, ethical, and cost-effective way ...

A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research ...

Researchers from the School of Engineering and Applied Science and the Perelman School of Medicine, along with the Children's Hospital of Philadelphia, have developed a bioengineered chip that ...

Penn engineers and collaborators have built a living tumor on a chip to expose how cancers block immune attacks, and how one existing drug could make immunotherapy like CAR T more effective against ...